Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Veronika Bachanova

Clinical trials sponsored by Veronika Bachanova, explained in plain language.

Trials to join now! 1

New Two-Drug attack on Tough-to-Treat hodgkin lymphoma

Disease control Recruiting now

This study is testing a combination of two drugs, nivolumab and ruxolitinib, for adults whose Hodgkin lymphoma has returned or not responded to prior treatments. The first part aims to find the safest dose of ruxolitinib to give with nivolumab. The second part will see how well t…

Phase: PHASE1, PHASE2 • Sponsor: Veronika Bachanova • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC